Taking the opportunity of global borders reopening, leaders of our laboratory units across the world gathered in Singapore for the inaugural IHH Laboratories Strategic Retreat that was held over 2 days on 18 & 19 July.
The retreat led by Ashok Pandit, Group Chief Strategy & Business Development Officer, was filled with dynamic discussions, alignment of strategies and synergy amongst 50 over attendees from our global labs, Legal, Finance, HR and Corporate Communications business units.
‘Developing the laboratory business’, as shared by Dr Kelvin Loh, Managing Director & CEO, earlier this year, is one of our new growth peaks and core business of IHH Healthcare.
“Post-Covid megatrends certainly favour the laboratory business; there is huge growth potential as the healthcare consumer goes beyond illness to wellness testing.”- Dr Kelvin Loh
With this growth opportunity in mind, our leaders of major laboratory units such as Pantai Premier Pathology in Malaysia, Parkway Laboratories in Singapore, Acibadem's LabMed in Turkey and Fortis’ SRL Diagnostics in India, held fervent conversations & consultations with one another on how we can develop better healthcare solutions for our consumers with topics ranging from ‘Investing in the Future’ to the ‘Importance of Data & Digitalisation’.
It is heartening to know that beyond the discussions of developing our laboratory business, the core of wanting to do better and emerging stronger, comes with the commitment of our purpose in touching lives and transforming care for our patients.
Here’s to the next laboratory retreat!
Related Stories
Gleneagles JPMC Collects 418kg of Waste in Beach Clean-Up Effort
Celebrate our Brunei colleagues for stepping beyond the hospital walls to make a real, measurable impact on the environment.
.png?sfvrsn=36e1af94_1)
Fortis Hospital Bannerghatta Road Successfully Treats Rare Nasal Tumour in Teen
After nearly two years of misdiagnosis, a 14-year-old boy suffering from a rare nasal tumour found a new lease of life at Fortis Hospital Bannerghatta Road.
Mount Elizabeth’s Revitalisation Sets a New Benchmark for Patient-Centred Care in the Region
IHH Healthcare Singapore is strengthening its legacy of care through the revitalisation of Mount Elizabeth Hospital (MEH), a flagship institution that has supported patients from Singapore, Indonesia and across the region for more than 45 years.
Fortis Charts the Future of Haematology
On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.
Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation
IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.
